GMO TRUST
NSAR-A, EX-27, 2000-10-27
Previous: GMO TRUST, NSAR-A, EX-27, 2000-10-27
Next: GMO TRUST, NSAR-A, EX-27, 2000-10-27



<TABLE> <S> <C>

<ARTICLE> 6
<LEGEND>
This schedule contains summary financial
information extracted from GMO Trust, form
N-SAR for the period ended August 31, 2000
and is qualified in its entirety by reference
to such financial statements.
</LEGEND>
<SERIES>
   <NUMBER> 253
   <NAME> GMO World Equity Allocation Fund, Class III

<S>                             <C>
<PERIOD-TYPE>                                         6-MOS
<FISCAL-YEAR-END>                               FEB-28-2001
<PERIOD-END>                                    AUG-31-2000
<INVESTMENTS-AT-COST>                           10,908,151
<INVESTMENTS-AT-VALUE>                          11,182,493
<RECEIVABLES>                                        1,829
<ASSETS-OTHER>                                           0
<OTHER-ITEMS-ASSETS>                                     0
<TOTAL-ASSETS>                                  11,184,322
<PAYABLE-FOR-SECURITIES>                                 0
<SENIOR-LONG-TERM-DEBT>                                  0
<OTHER-ITEMS-LIABILITIES>                            9,371
<TOTAL-LIABILITIES>                                  9,371
<SENIOR-EQUITY>                                          0
<PAID-IN-CAPITAL-COMMON>                        16,110,351
<SHARES-COMMON-STOCK>                            1,225,592
<SHARES-COMMON-PRIOR>                            1,209,140
<ACCUMULATED-NII-CURRENT>                           98,761
<OVERDISTRIBUTION-NII>                                   0
<ACCUMULATED-NET-GAINS>                                  0
<OVERDISTRIBUTION-GAINS>                        (5,308,503)
<ACCUM-APPREC-OR-DEPREC>                           274,342
<NET-ASSETS>                                    11,174,951
<DIVIDEND-INCOME>                                   98,666
<INTEREST-INCOME>                                      328
<OTHER-INCOME>                                           0
<EXPENSES-NET>                                           0
<NET-INVESTMENT-INCOME>                             98,994
<REALIZED-GAINS-CURRENT>                           469,434
<APPREC-INCREASE-CURRENT>                           55,721
<NET-CHANGE-FROM-OPS>                              624,149
<EQUALIZATION>                                           0
<DISTRIBUTIONS-OF-INCOME>                         (432,872)
<DISTRIBUTIONS-OF-GAINS>                                 0
<DISTRIBUTIONS-OTHER>                                    0
<NUMBER-OF-SHARES-SOLD>                                  0
<NUMBER-OF-SHARES-REDEEMED>                              0
<SHARES-REINVESTED>                                 16,452
<NET-CHANGE-IN-ASSETS>                             340,822
<ACCUMULATED-NII-PRIOR>                            432,639
<ACCUMULATED-GAINS-PRIOR>                                0
<OVERDISTRIB-NII-PRIOR>                                  0
<OVERDIST-NET-GAINS-PRIOR>                      (5,777,937)
<GROSS-ADVISORY-FEES>                                    0
<INTEREST-EXPENSE>                                       0
<GROSS-EXPENSE>                                     10,396
<AVERAGE-NET-ASSETS>                            11,105,573
<PER-SHARE-NAV-BEGIN>                                 8.96
<PER-SHARE-NII>                                       0.08
<PER-SHARE-GAIN-APPREC>                               0.44
<PER-SHARE-DIVIDEND>                                 (0.36)
<PER-SHARE-DISTRIBUTIONS>                             0.00
<RETURNS-OF-CAPITAL>                                  0.00
<PER-SHARE-NAV-END>                                   9.12
<EXPENSE-RATIO>                                       0.00


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission